Capricor Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -8.70%
- Market cap
- $595.08M
- 58.14M shares
- Filings
- 967
FY 2025−100.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+2,450.3% FY25 yoy
- $595.08M
- —
- —
- 2.8×
- -12.22%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $22,270,465 | reported | |
| FY 2023 | 2023-12-31 | $25,178,066 | reported | |
| FY 2022 | 2022-12-31 | $2,600,000 | reported | |
| FY 2021 | 2021-12-31 | $244,898 | reported | |
| FY 2020 | 2020-12-31 | $310,250 | reported | |
| FY 2019 | 2019-12-31 | $1,005,028 | reported | |
| FY 2018 | 2018-12-31 | $1,671,356 | reported | |
| FY 2017 | 2017-12-31 | $2,666,340 | reported | |
| FY 2016 | 2016-12-31 | $3,998,618 | reported | |
| FY 2015 | 2015-12-31 | $5,517,648 | reported | |
| FY 2014 | 2014-12-31 | $4,786,700 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2020 | — | $0.00 | $0.00 | — | 22.80M sh | +155.9% | — |
| FY2019 | — | $193.00 | $193.00 | — | 8.91M sh | −73.5% | — |
| FY2018 | — | $0.00 | $0.00 | — | 33.66M sh | +21.5% | — |
Pharmaceutical preparations
Capricor Therapeutics, Inc. is the 179th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GERNGeron Corp———$636.4MACRSAclaris Therapeutics, Inc.$7.8M58.2%829.6%$635.2MQNRXQuoin Pharmaceuticals Ltd.———$628.9MANNXAnnexon, Inc.———$625.8MWVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MABUSArbutus Biopharma Corp$14.1M128.2%237.9%$617.8MEVOEvotec SE———$595.6M
CAPRCapricor Therapeutics, Inc. (this company)$0.0100.0%—$595.1M
CBIOCrescent Biopharma, Inc.$10.8M—1,419.6%$561.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR